MERRIMACK PHARMACEUTICALS INC (16) | Purchase Agreements (4)
Recent Contracts
-
Asset Purchase Agreement, dated as of March 27, 2020, between Merrimack Pharmaceuticals, Inc. and Celator Pharmaceuticals, Inc
(Filed With SEC on March 30, 2020)
-
Amendment No. 2 to Asset Purchase Agreement, dated as of June 28, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc
(Filed With SEC on July 1, 2019)
-
Amendment No 1. to Asset Purchase Agreement, dated as of June 24, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc
(Filed With SEC on June 24, 2019)
-
Asset Purchase Agreement, dated as of May 28, 2019, by and between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc
(Filed With SEC on May 30, 2019)